The gram-negative anaerobic pathogen Porphyromonas gingivalis has been implicated as a key etiological agent of destructive periodontal disease (21, 37, 43) . The major proteinases released by the bacterium hydrolyze peptide bonds after arginyl (gingipain-R; RgpA) or lysyl residues (gingipain-K; Kgp) (36) . A polypeptide product of one gingipain locus, RgpA, consists of a pre-pro-fragment, a 50-kDa catalytic domain, and hemagglutinin domains (34) . The kgp gene also encodes a pre-pro-fragment, a 60-kDa catalytic domain, and hemagglutinin domains (35) . Gingipains isolated from P. gingivalis are potent enzymes with activity against a wide range of substrates, including matrix metalloproteinases (9) , complement factors (10, 52) , immunoglobulins (25, 44) , fibronectin (29, 51) , proteinase inhibitors (5, 20) , coagulation factors (32) , the fibrinogen/fibrin pathway (28) , and the kallikrein-kinin system (23, 24) . These proteinases participate in the degradation of periodontal tissues directly or indirectly as activators or inactivators of the host immune system. There is considerable evidence to suggest that proinflammatory cytokines, including interleukin 1␤ (IL-1␤), IL-6, and tumor necrosis factor alpha (TNF-␣) are degraded by P. gingivalis hydrolases (4, 12, 13) .
The progression of periodontal disease is not clearly understood but is characterized by a local accumulation of activated leukocytes (33) . Cytokines produced locally probably have an influence on the development of this immune response (14) . Of these cytokines, IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, gamma interferon (IFN-␥), transforming growth factor-␤, and TNF-␣ are all implicated (26, 50) . The synergistic action of IFN-␥ and TNF-␣ in inflammation is well established where IFN-␥ enhances TNF-␣ production and/or activity.
IFN-␥ plays an essential role in the regulation of variety of immune functions. It is produced by antigen-specific T cells and natural killer cells recruited by IL-2, and it has been shown to occur in a pattern similar to that of a controlled delayedtype hypersensitivity response in the gingivitis lesion (41) . Lower levels of IFN-␥ in periodontal disease lesions may result in decreased Th1 phenotype responses (16) . It has been suggested that the stable and progressive lesions are regulated by antigen-specific Th1 phenotype and Th2 phenotype cells, respectively (18, 19) .
Major histocompatibility complex class II (MHC-II) molecules are heterodimeric transmembrane glycoproteins consisting of ␣ and ␤ chains (2) . The different MHC-II isotypes (HLA-DR, -DQ, and -DP in humans) are encoded by distinct ␣-chain and ␤-chain genes (47) . MHC-II molecules are essential in order to present peptides generated in the intracellular vesicles of endothelial cells, macrophages, and other antigenpresenting cells to CD4 ϩ T helper lymphocytes (38) . A lack of MHC-II expression is known to result in severe immunodeficiency (31) .
IFN-␥ is a pleiotropic cytokine with immunomodulatory effects on a variety of immune cells (11) . IFN-␥ is required to upregulate MHC class II proteins and Fc␥ receptor expression on macrophages and many other cells, including endothelial cells, lymphoid cells, mast cells and fibroblasts to influence the ability of these cells to present antigen during the induction phase of immune responses (3, 53) . IFN-␥ is also known as the main factor regulating immunoglobulin G2 (IgG2) switching in mouse B cells challenged with lipopolysaccharide. In periodontitis subjects with progressive lesions, low-avidity antibodies, particularly of the IgG2 class, which lack strong complement fixation and opsonization properties, appear to dominate (49) .
IFN-␥ has been detected by various means in cases of periodontitis (16, 17, 19) , but the biological activity of the measured protein was not presented in these studies.
We present here evidence that P. gingivalis proteinases are able to cleave the human IFN-␥ molecule but not the HLA-DR molecule or the human IFN-␥ receptor ␣ and ␤ chains on human umbilical vein endothelial (HUVE) cells. Also, we demonstrate that degradation occurs at the carboxyl terminal of the IFN-␥ in the absence or presence of serum to inactivate the ability of IFN-␥ to induce HLA-DR expression in endothelial cells. 
MATERIALS AND METHODS

Chemicals
, collagenase type 1A, endothelial cell growth factor, trypsin, recombinant IFN-␥ (rIFN-␥), and native IFN-␥ (nIFN-␥) were purchased from Sigma Chemical Co., St. Louis, Mo. Mercuric chloride (HgCl 2 ), Tween 20, and M199 medium were obtained from ICN Biochemicals, Irvine, Calif. 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) was purchased from Calbiochem, La Jolla, Calif. Phosphate-buffered saline (PBS) was purchased from Oxoid. All reagents for electrophoresis and Western blotting were from Bio-Rad, Richmond, Calif.
RgpA and Kgp isolation. P. gingivalis (ATCC 33277) cells were grown in enriched Trypticase soy broth (Difco, Detroit, Mich.) under anaerobic conditions for 48 h (7). The bacterial pellet was then extracted in 0.05 M Tris-1 mM CaCl 2 (pH 7.5) (Tris buffer) with 1% CHAPS, a nondenaturing zwitterionic detergent, by gentle mixing for 2 h (8). Insoluble material was separated from the detergent extract by centrifugation (8,000 ϫ g, 15 min, 4°C), and the supernatant was passed over a Mono-Q fast-protein liquid chromatography column (Pharmacia, Uppsala, Sweden) equilibrated with Tris buffer containing 1% CHAPS at a flow rate of 60 ml h
Ϫ1
. After being loaded and washed, the proteins were eluted from the column with the same buffer containing 1 M sodium chloride. The Mono-Q eluant was dialyzed against Tris buffer, and final purification was achieved by affinity chromatography over an arginine-Sepharose column (XK 26; Pharmacia) previously equilibrated with Tris buffer. The dialyzed sample was applied at a flow rate of 60 ml h
, and then the column was washed with 0.5 M NaCl in the same buffer. Kgp was eluted with 0.75 M L-lysine (pH 7.4). After re-equilibration, RgpA was eluted with 1 M L-arginine (pH 7.4).
Enzyme activity assays. The amidolytic activities of the purified RgpA and Kgp were measured with the substrates GPR-pNA (1 mM) and GPK-pNA (1 mM). Then, 1 g of RgpA or Kgp was preincubated in Tris buffer containing 5 mM cysteine for 5 min at room temperature. The enzyme and the substrate were combined, and the rates of hydrolysis were measured at 37°C on the basis of the increase in A 414 as measured with a Titertek Twinreader PLUS photometer (Flow Lab). To measure the effect of stimulating agents or inhibitors on the activated gingipains, the compounds were preincubated with enzyme at room temperature for up to 30 min in assay buffer prior to assay for residual amidolytic activities.
Measurement of kinetic constants for Arg-gingipain and Lys-gingipain. Experiments were carried out in which RgpA or Kgp was preincubated in Tris buffer containing 5 mM L-cysteine for 15 min at 37°C. The activated RgpA or Kgp (160 fM each) was then added to the stock substrate solution (160 M) at 37°C for 10 min, and the reaction was stopped in aliquots with TLCK (2 mM). Aliquots were resolved by 14% polyacrylamide gels by SDS-polyacrylamide gel electrophoresis (PAGE) for Western blot analysis with rabbit anti-human IFN-␥ polyclonal antibodies (Endogen). Hydrolysis of rIFN-␥ was measured as the cleaved rIFN-␥ product, which is proportional to the increase in density as determined by densitometry, thereby allowing determination of the kinetic parameters K m and V max .
Endothelial cell isolation and culture. HUVE cells were isolated and cultured as described previously (46) . Briefly, the cells were obtained by treatment of fresh human umbilical cord with collagenase type 1A and then serially cultured. Culture medium M199 was supplemented with 20% fetal calf serum (FCS) (Trace Biosciences, Ltd.), 10 U of heparin (DBL) per ml, 30 g of endothelial cell growth factor per ml, 50 U of penicillin per ml, and 50 g of streptomycin per ml. Cells used in these experiments were confluent and at passage levels 4 through 6. Endothelial cells were identified by reaction with Ulex agglutinin (Dako).
Endothelial cell assay conditions. HUVE cells were seeded at a density of 10 SDS-PAGE and Western blot analysis. Proteins were resolved in 14% polyacrylamide gels (SDS-PAGE) (27) and transferred to polyvinylidene difluoride membrane essentially as described by Towbin et al. (48) . The membranes were then incubated for 2 h in 20 mM Tris with 500 mM NaCl buffer (Tris-buffered saline) containing 0.1% Tween 20 and 4% skim milk (blocking buffer). IFN-␥ was detected with either polyclonal rabbit anti-human IFN-␥ (Endogen) or polyclonal goat anti-human IFN-␥, which recognizes the epitope corresponding to amino acids 148 to 166 mapping at the carboxy terminus of the IFN-␥ precursor (Santa Cruz Biotechnology). Either alkaline phosphatase goat anti-rabbit (Dako) or biotin-labeled rabbit anti-goat IgG (Dako) was used as the secondary antibody accordingly. Biotin was detected with streptavidin-alkaline phosphatase (Dako), and color was developed in a solution containing nitroblue tetrazolium chloride (1.65 mg) and 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt (0.8 mg) in 5 ml of 100 mM Tris-HCl (pH 9.5) containing 100 mM NaCl and 50 mM MgCl 2 . Membranes were washed three times in Tris-buffered saline-0.1% Tween after each step. The HLA-DR was detected with monoclonal mouse anti-human HLA-DR antibodies which recognize the ␣ or ␤ chains, respectively (Dako). The IFN-␥ receptor (R) was detected with polyclonal antibody specific for amino acids 466 to 485 mapping at the COOH-terminal domain of the human IFN-␥ R ␣ chain or detected with polyclonal antibody specific for the amino acids 318 to 337 mapping at the COOH-terminal domain for IFN-␥ R ␤ chain (Santa Cruz Biotechnology).
RESULTS
Characterization of the proteinase preparations. The RgpA and Kgp isolated from the cellular fraction of P. gingivalis had activity and inhibition profiles characteristic of the gingipains previously published (Tables 1 and 2 ). Based on activity profiles, RgpA preparation was ϳ99% pure with 1% Kgp contamination, whereas Kgp preparation was ϳ85% pure with 15% RgpA contamination. Boiling and reduction of the gingipains (denaturation) resulted in more complex SDS-PAGE banding patterns that were characteristic of gingipains previously described (Fig. 1) . NH 2 -terminal sequencing confirmed the identity of the peptide fragments as RgpA and Kgp domains (data not shown).
Cotreatment of HUVE cells with rIFN-␥ and gingipains. Nonstimulated HUVE cells in culture did not express HLA-DR antigen, as measured by flow cytometric analysis (Fig. 2a) , but they could be induced to express DR antigen by incubation with rIFN-␥ (Fig. 2b) . RgpA or Kgp (the effect of Kgp is not shown) at concentrations of 60 nM in serum-containing culture medium eliminated the surface expression of HLA-DR to control levels on HUVE cells when added simultaneously with 3 nM rIFN-␥ (Fig. 2c) . When the gingipains were added either 1 or 2 days after the rIFN-␥, the HLA-DR expression was limited in a time-dependent manner ( Fig. 2d and e) . This activity of RgpA and Kgp was destroyed when the gingipains were heated for 30 min at 80°C, indicating that the effect was structurally labile and was not due to toxicity (data not shown). The cysteine proteinase inhibitor TLCK (2 mM, final concentration) was able to block the effect of both RgpA and Kgp (the effect of Kgp is not shown) (Fig. 3) . Finally, RgpA and Kgp each had a similar dose-dependent effect of limiting HLA-DR expression in HUVE cell cultures (Fig. 4) . The dose effects were linear to a concentration of 35 nM gingipain in the culture medium with a maximal effect near 75 nM. These data suggest that the effect of RgpA and Kgp on HLA-DR expression is associated with a free thiol and probably with protease activity of the gingipains.
The possibility that the decreased measurement of HLA-DR expression was due to the proteolytic activity of the RgpA or Kgp on HLA-DR molecules directly was examined. We incubated HUVE cells with rIFN-␥ for 3 days to induce HLA-DR expression and then washed the cells and added 60 nM RgpA or Kgp for a subsequent 24 h in culture in the presence of 5 mM L-cysteine. With specific antibodies against either the ␣-chain or ␤-chain monomorphic regions, no hydrolysis of the HLA-DR complex was detected after incubation of the cells with either RgpA or Kgp (Fig. 5) .
Since the gingipains limited the expression of HLA-DR which had been experimentally induced through the IFN-␥ pathway, we also examined whether the RgpA and Kgp were acting on the IFN-␥ receptor ␣ and ␤ chains of HUVE cells. As shown in Fig. 6 , we were not able to detect any hydrolysis of the IFN-␥ receptor ␣ or ␤ chains resulting from the addition of cysteine-activated RgpA and Kgp to HUVE cell cultures. These results suggested that the HLA-DR molecule and the IFN-␥ receptor ␣ and ␤ chains are resistant to proteolytic digestion by the gingipains.
Digestion of IFN-␥ by RgpA or Kgp in the absence or presence of serum. Both nIFN-␥ and rIFN-␥ were partially hydrolyzed by the gingipains in separate reactions, as determined by Western blot analysis. Proteolytic processing of nIFN-␥ in the presence of serum (Fig. 7) was rapid with a 1:1 enzyme-substrate (E:S) molar ratio but did not progress beyond the initial cleavage generating the 15-kDa fragment, even after an overnight incubation at 37°C. Incubation with either RgpA or Kgp gave similar results.
Proteolytic processing of rIFN-␥ also was similar with both the RgpA and the Kgp. As the reaction progressed over time, however, lower-molecular-size fragments were detected in serum-free conditions, with gradual loss of the remaining 15 kDa fragment at an E:S molar ratio of 1:28 (see Fig. 9 ). Hydrolysis of the rIFN-␥ was approximately 10-fold slower in the presence of 20% serum than in the absence of serum.
More-limited proteolysis of recombinant IFN-␥ (Fig. 8 ) in the absence of serum by RgpA or Kgp occurred at an E:S molar ratio of 1:1,000 and resulted in partial conversion of the 17-kDa rIFN-␥ to a 15-kDa fragment after 10 min of incubation. Importantly, IFN-␥ dimers demonstrated rates of hydrolysis similar to the monomers.
Degradation of rIFN-␥ by RgpA or Kgp in the presence of leupeptin and the kinetic characteristics. To determine the relative roles of RgpA and Kgp in IFN-␥ hydrolysis, reactions with RgpA and Kgp were carried out in the presence of 5 mM L-cysteine and 0.1 mM leupeptin, an inhibitor of RgpA and not Kgp (Fig. 9) . Although the RgpA preparation was shown to contain a low level of Kgp (Tables 1 and 2 Tables 1 and 2 ].) KGP exhibited a higher affinity for the rIFN-␥ as evidenced by lower K m value, while RgpA cleaved the rIFN-␥ more efficiently, with a higher V max value. These data provide supportive evidence that both RgpA and Kgp cleave rIFN-␥ efficiently. 
Cleavage of rIFN-␥ COOH-terminal epitope by RgpA or
Kgp results in loss of HLA-DR induction. Since human IFN-␥ has a number of basic amino acid residues (1) in the COOHterminal portion which may be processed by tryptic-like protease(s), we suspected that the conversion of the 17-kDa molecule to the 15-kDa fragment by gingipains was due to proteolysis in the COOH-terminal region of IFN-␥ and was associated with a loss of biological activity. To demonstrate this, the rIFN-␥ was incubated with various concentrations of RgpA or Kgp for different periods of time, and the reactions were stopped with TLCK. Aliquots of the digests were analyzed by Western blot by using a polyclonal antibody directed against the COOH terminus of the rIFN-␥ molecule. To replicate the incubation condition in the HUVE cell cultures, aliquots of the same digests were also dialyzed and applied to HUVE cell cultures to assess HLA-DR induction. Loss of the COOH terminus detected by Western blot analysis (Fig.  10a to c) corresponded with loss of HLA-DR induction ( Fig.  10d and e) .
DISCUSSION
The results of this study demonstrated that both the Arggingipain and Lys-gingipain of P. gingivalis could rapidly cleave and inactivate the IFN-␥ molecule. Treatment of native glycosylated human IFN-␥ with P. gingivalis cysteine proteinases resulted in the generation of a fragment which displays an M r of 15,000, with some further degradation occurring after prolonged incubation. Both the cysteine-activated RgpA and Kgp cleaved the human IFN-␥ molecule within 10 min, with the further degradation of IFN-␥ by Kgp occurring at a slower rate. Proteolysis also occurred in the presence of serum inhibitors, a finding which is consistent with the findings from flow cytometric analysis, where the P. gingivalis cysteine proteinases decreased the expression of HLA-DR molecules on HUVE cells in the presence of 20% FCS in a dose-and time-dependent manner. The proteinase inhibitors ␣ 2 -macroglobulin and ␣ 1 -antitrypsin, which are responsible for most of the total proteinase-inhibitory capacity of plasma (5), may play significant roles in protecting tissues from proteolytic enzymes released in infected sites. Resistance to plasma inhibitors and preferential cleavage of IFN-␥ in the presence of plasma proteins, which is possibly related to IFN-␥ structure, implies a role for the gingipains in driving an ineffective immune response.
Cleavage rates of rIFN-␥ by gingipain-R and gingipain-K exhibit very similar kinetics. Although gingipain-R proceeded with a higher kinetic constant than gingipain-K, this was balanced by the higher affinity constant of gingipain-K. In relation to the high conservation of the noncatalytic regions of these enzymes, the detected differences are potentially attributable to structural heterogeneity within the catalytic domains.
The regulatory effects of IFN-␥ include induction of HLA-DR expression, activation of macrophages to enhance phagocytic capability as well as activation and growth enhancement of cytotoxic T lymphocytes and natural killer cells. Cleavage of IFN-␥ may disrupt locally the host's defense against microbial pathogens by affecting the antigen-presenting activity of macrophages. Of note, studies in our laboratory have demonstrated the functional anergy of macrophages in advanced periodontitis lesions (6) .
The IFN-␥s from different sources show similarity in sensitivity to P. gingivalis cysteine proteinases. The glycosylated form from human lymphocytes and the unglycosylated IFN-␥ from E. coli were both degraded by the gingipains. Human IFN-␥ is a well-characterized secretory glycoprotein that has two potential glycosylation sites at asparagine 25 (Asn 25 ) and asparagine 97 (Asn 97 ) at the consensus sequences Asn-X-Thr and Asn-X-Ser, respectively. Natural IFN-␥ has three forms that are different in glycosylation: diglycosylated at Asn 25 and Asn 97 (2N), monoglycosylated at Asn 25 (1N), and nonglycosylated (22) . Results indicate that the sugar side chains are ineffective in protecting the gingipain cleavage sites of the proteins on the IFN-␥ molecule, although the glycan residues constitute 15 to 25% of the molecular mass of the protein.
From the immunoblot analysis with polyclonal antibody to detect the human IFN-␥ molecule, one major fragment corresponding to 15 kDa was observed after incubation at 37°C, whereas with the polyclonal antibody specific for the COOH terminus of the IFN-␥ molecule, this band was not observed, indicating that the 15-kDa fragment lacks the COOH-terminal epitope. Based on the molecular size difference between the intact rIFN-␥ and the 15-kDa protein, we suggest the latter lacks 13 to 14 amino acids at the COOH terminus. Since the COOH terminus-directed antibody was made against a sequence of 19 COOH-terminal residues of intact rIFN-␥, removal of the 13 or 14 COOH-terminal residues could destroy the immunoreactivity of the protein. Thus, based on the above data, cleavage of the rIFN-␥ with P. gingivalis cysteine proteinases occurred probably at the carboxylic side of Arg-129 or Lys-130.
From the flow cytometric analysis, it is significant that the pretreatment of rIFN-␥ or nIFN-␥ with gingipain correlated with the loss of induction of HLA-DR. It is therefore likely that the loss of inducing activity of MHC-II expression with the digested IFN-␥ molecule is due to the removal of the 13 to 14 amino acids at the COOH-terminal end of IFN-␥. These data are consistent with other studies which have indicated that enzymatic removal of residues 129 to 143 of the protein with endopeptidases such as clostripain (30) or trypsin (1) results in a 10-to 100-fold reduction in IFN-␥'s specific antiviral activity.
In chronic inflammatory periodontal disease, the predominant lymphocyte in the stable lesion of gingivitis is the Th1 phenotype cell, while increased proportions of B cells and plasma cells can be demonstrated in the progressive lesion (42, 45) . IFN-␥ may be essential for the induction of Th1 phenotype with an inhibitory effect on Th2 cell profile (15, 39, 40) . Inactivation of IFN-␥ by gingipains from P. gingivalis could lead to proliferation of Th2 phenotype cells and locally to mediate progression of the periodontal lesion.
We are beginning clinical studies to investigate the status of IFN-␥ present in the gingival fluid and tissues, and preliminary evidence indicates that IFN-␥ hydrolysis is present in diseased but not in healthy samples. Chronic inflammatory periodontal disease, however, must be seen to be multifactorial in etiology and pathogenesis, and it is difficult to link these findings to the situation in vivo. These data do, however, suggest another, potentially important mechanism for virulence of P. gingivalis and the gingipains. To conclude, proteolysis of IFN-␥ and other cytokines by P. gingivalis may disturb the complex cytokine network responsible for maintaining a protective response to bacterial challenge.
